Table of Contents 1370 MSAC and PASC 5 Final Protocol to guide the assessment of Purpose of this document 5 optical coherence tomography for the Purpose of application 6 determination of eligibility and efficacy Background 6 assessment of treatment with ocriplasmin Vitreoretinal interface disorders 6 (JETREA®) Ocriplasmin 10 OCT 10 Regulatory status 11 OCT 12 Ocriplasmin 12 May 2014 Current arrangements for public reimbursement 12 OCT 12 Ocriplasmin 14 Intervention 14
1370 Final Protocol to guide the assessment of optical coherence tomography for the determination of eligibility and efficacy assessment of treatment with ocriplasmin (JETREA®) May 2014 Table of Contents MSAC and PASC 5 Purpose of this document 5 Purpose of application 6 Background 6 Vitreoretinal interface disorders 6 Ocriplasmin 10 OCT 10 Regulatory status 11 OCT 12 Ocriplasmin 12 Current arrangements for public reimbursement 12 OCT 12 Ocriplasmin 14 Intervention 14
1370-OCT%20for%20sVMA%20-Final%20Protocol%20accessible(D14-1103373).docx